Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

31 Mar 2021 07:00

RNS Number : 9447T
Sopheon PLC
31 March 2021
 

SOPHEON PLC

("Sopheon" or the "Company")

 

Directorate Change

 

Gregory Coticchia appointed as Chief Executive Officer

 

Sopheon, an international global leader in enterprise innovation management solutions, is pleased to announce that Gregory Coticchia has today joined the Board in the role of Chief Executive Officer.

 

Since 12 October 2020 Greg, who is based in the USA, has served as President of Sopheon responsible for the day to day operations, with a focus on accelerating the Company's SaaS transition and to spearhead cloud development plans.

 

Prior to his appointment Greg worked as a consultant to the Company. Greg has deep experience in cloud software products and services, holding executive roles in several organizations ranging from start-ups to $1bn revenue businesses, where he has been responsible for driving both organic and acquisition-led growth. This includes stints serving as CEO, President or COO, as well as marketing leadership roles. He has launched several new companies, either as lead entrepreneur or through incubation. Alongside his leadership and business credentials, he has been involved or responsible for the launch of over 100 products and solutions and is a recognized authority within the fields of product management and product development. Underlining his achievements, prior to joining Sopheon, Greg was asked to establish the Master's Program in Product Management at Carnegie Mellon University, and then served as the executive director of the program while continuing to provide business coaching and consulting to a variety of corporate organizations.

Greg Coticchia commented: "Digital transformation continues to accelerate, and innovation is an urgent imperative for virtually every company. Sopheon has a large opportunity to build off the very impressive client base and grow through the expansion of new cloud solutions. I am both honoured and excited to lead Sopheon in this next phase of growth."

As part of this planned transition strategy, Andy Michuda has become Executive Chairman of Sopheon's Board of Directors. Andy will focus on partnerships and acquisitions, in addition to his governance responsibilities. Barry Mence, who has been Chairman of the Board since the Company's inception, will serve as a non-executive director of Sopheon and remain a major shareholder in the Company.

Andy Michuda commented: "On behalf of the Sopheon Board, I would like to officially give a warm welcome to Greg as our new Chief Executive Officer. Greg's experience and track record in software and innovation are invaluable. He has already had a significant impact on the business in his short tenure as President. With Greg as our Chief Executive, I believe we are well placed to continue to deliver our SaaS transition, and to access a number of major growth opportunities in the future. I look forward to working alongside Greg to deliver value for Sopheon shareholders over the coming years."

The following information regarding the appointment of Gregory Michael Coticchia (aged 60) is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies.

As at the date of this announcement Greg holds no ordinary shares in the Company and 20,000 options over ordinary shares.

Current Directorships or Partnerships

Previous Directorships or Partnerships held in the past 5 years

ENTRA, Incorporated

PGHPCamp

Axiom Advancement Corp.

None

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

 

For further information contact:

Andy Michuda, ChairmanArif Karimjee, CFO

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes / Giles Rolls (Corporate Finance)Alice Lane / Sunila de Silva (ECM)

finnCap

+ 44 (0) 20 7220 0500

 

About Sopheon.  Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAXDEDSKFEEA
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.